Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-18

Clinical Trial Update: Pancreatic Perfusion Using Secretin and MRI [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a phase 1/2 clinical trial studying pancreatic perfusion using secretin and MRI for chronic pancreatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Secretin (secretin)

Snippet

Sponsor: University of Nottingham | Conditions: Chronic Pancreatitis | Phase 1, Phase 2 | Status: UNKNOWN